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Abstract
Background: The objective of this study was to describe the intake of macronutrient, especially fatty acids, and
explore their possible effect on diabetic retinopathy (DR) in patients with type 2 diabetes mellitus.
Methods: In this case–control study, we included a total of 146 patients with DR and 148 without DR. The intake of
macronutrient was evaluated using a validated food frequency questionnaire. We used logistic regression adjusted
for sex, age, diabetes duration, energy intake, educational level, physical activity, waist circumference, systolic blood
pressure, high-density lipoprotein cholesterol and diabetes treatment, to estimate odds ratio (ORs) of DR.
Results: Patients with DR had significantly lower intake of fibre, monounsaturated fatty acids (MUFA), and palmitic
and oleic acid. Inverse associations were observed between MUFA and oleic acid intake in DR. Subjects with
intermediate and high MUFA intake were less likely to have DR than those with lower MUFA intake, with ORs of 0.
46 (95 % CI: 0.22–0.93) and 0.42 (95 % CI: 0.18–0.97), respectively. Similarly, intermediate and high oleic acid intake
were associated with reduced DR frequency compared with low oleic acid intake, with OR values of 0.48 (95 % CI: 0.
23–0.97) and 0.37 (95 % CI: 0.16–0.85), respectively. These associations were stronger in patients with a longer
diabetes duration.
Conclusion: In type 2 diabetes mellitus, MUFA and oleic acid intake were inversely associated with DR.
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Background
Diabetic retinopathy (DR) is an ophthalmological com-
plication of diabetes mellitus and is the main cause of
non-recoverable vision loss in the working-age popula-
tion [1]. In Spain, DR is still a relatively frequent diabetic
microangiopathic complication [2].
The development of DR is determined by multiple con-
tributing factors: duration and magnitude of hyperglycaemia,
high blood pressure, dyslipidaemia, smoking, oxidative
stress, inflammation, platelet dysfunction and several
genetic factors [1, 3]. However, there is little evidence
concerning the potential role of nutrients as protective
factors against DR. Two intervention studies in humans
showed a potential protective role of unsaturated fatty
acids, especially linoleic acid, against the development
and progression of DR in patients with type 2 diabetes
mellitus (T2DM) [4, 5]. In a recently published post-
hoc analysis from the PREDIMED intervention study, a
Mediterranean diet supplemented with extra virgin
olive oil showed a protective effect against retinopathy
[6]. In a population-based cross-sectional study in pa-
tients with T2DM in India, low fibre intake was identi-
fied as a risk factor for the development of DR [7]. Tanaka
et al. demonstrated that increased fruit consumption is
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associated with a lower incidence of DR in a cohort of
Japanese patients with T2DM who followed a low-fat,
energy-restricted diet [8]. In a small cross-sectional study,
diabetic patients without retinopathy had higher fibre and
carbohydrate intake and a lower proportion of dietary en-
ergy from protein than their counterparts with retinopathy
[9]. However, these results are far from consistent.
In this study, we describe the intake of macronutri-
ents, especially fatty acids, and explore their association
with diabetic retinopathy (DR).
Methods
Study design and subjects
In this case–control study, we included a total of 146
type 2 diabetic patients with DR and 148 type 2 diabetic
patients without DR. All of the participants were aged
40 to 75 years. The primary recruitment of the cases
took place within the previously published diabetic retin-
opathy screening and treatment program of the Depart-
ment of Ophthalmology [10]. Participants in that former
study were offered dietary questionnaires to participate
in this study, and only 5 declined (response rate: 98.3 %).
Retinopathy status was assessed and classified by an ex-
perienced ophthalmologist following an international
clinical classification system [11]. The presence of the
following advanced diabetes complications was an exclu-
sion criterion: renal disease (macroalbuminuria or renal
insufficiency) and cardiovascular disease. These exclu-
sion criteria were defined in the initial design of the
study as they are known to affect quality of life which
was one of the main outcomes of the original study [10].
The recruitment process took place between March
2010 and January 2013. The local ethics committee ap-
proved the study, and all study subjects signed a written
informed consent form.
Clinical and socio-demographic variables
A detailed description of the methodology of assess-
ment of the clinical variables was recently published
[10]. The following socio-demographic and clinical
characteristics were collected: age, sex, diabetes dur-
ation, self-reported ethnic group, smoking habits, phys-
ical activity, level of education, blood pressure, lipid
profile, antidiabetic treatments, antihypertensive and
hypolipidaemic treatments, and glycated haemoglobin
(HbA1c).
Dietary data
Food and nutrient intake was assessed using a 101-food
item semiquantitative food frequency questionnaire (FFQ)
(available at: http://bibliodieta.umh.es/cfa-101-inma). The
FFQ was an adapted version of the questionnaire by Willett
et al. [12] and validated for Spanish populations [13]. The
mean correlation coefficients between the nutrient intakes
estimated using prospectively collected diet records and
those estimated with the FFQ were 0.47 for validity and
0.40 for reproducibility [14]. The questionnaires were re-
leased to and controlled by one of the researchers (N.A.) on
an individual basis. Participants were asked to report how
often, on average, they had consumed each food item over
the past year. Serving sizes were specified for each food
item in the food frequency questionnaire (FFQ). The ques-
tionnaire offered nine options for frequency of consump-
tion for each food, ranging from “never or less than once a
month” to “6 or more times/day”. Nutrient values for each
food in the questionnaire were mainly obtained from food
composition tables of the US Department of Agriculture
and supplemented with Spanish sources [15, 16].
Sample size
The inclusion of a minimum of 146 individuals in each
group (DR and no DR patients) was sufficient to achieve an
80 % statistical power (β = 0.2) with a 5 % significance level
(α = 0.05) to detect a difference of at least 40 g in the carbo-
hydrate intake, 81 mg in cholesterol intake, and 3.2 g in
fibre intake (assuming standard deviations of 104.5, 215.0
and 8.3, respectively). The data for standard deviations were
based on the results published in a previous study con-
ducted in Spain [17].
Statistical analysis
Means (and standard deviations) and absolute and relative
frequencies (in percentages) were computed for quantita-
tive and qualitative variables, respectively. The differences
in the clinical and sociodemographic characteristics be-
tween the DR and no DR patients were assessed using a
Chi-squared test or Fisher’s exact test for comparison of
qualitative variables and Student’s t test for comparison of
quantitative variables. Logistic regression analyses were
fitted to assess the association between the macronutrient
intake, especially fatty acids, and DR adjusted for sex, age,
diabetes duration and energy intake. In a subsequent
model we also adjusted for all significant covariates in the
univariate analysis (p value < 0.20), such as educational
level, physical activity, waist circumference, systolic blood
pressure, high-density lipoprotein cholesterol (HDL-chol-
esterol) and diabetes treatment. Tests for linear trends in
the tertiles of nutrient intake were evaluated introducing
the variable (1, 2, 3) as a continuous term in the logistic
regression models. To explore the effect of the duration of
diabetes (categorization based on a median diabetes dur-
ation ≤ 8 years vs > 8 years) on the association between
macronutrients and DR, the models were stratified by dur-
ation of diabetes.
Results
Table 1 shows the clinical and socio-demographic charac-
teristics of the study participants according to DR status.
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Patients with DR were older and had a lower education
level. Patients with DR also had a longer diabetes duration,
were more frequently treated with insulin, and had higher
HbA1c concentrations than patients without DR.
The mean daily nutrient intakes were very similar in
patients with DR and patients without DR (Table 2).
However, the patients with DR showed a lower intake of
fibre, monounsaturated fatty acids, and palmitic and
oleic acid.
The adjusted logistic regression analysis revealed that
there was an inverse linear association between monoun-
saturated fatty acid intake tertiles and DR (p = 0.034) and
between oleic acid intake tertiles and DR (p = 0.017). The
fully adjusted ORs (95%CIs) for categories of intermediate
and high monounsatured fatty acid consumption com-
pared with the low consumption were 0.46 (0.22–0.93)
and 0.42 (0.18–0.97), respectively. In addition, adjusted
ORs (95 % CIs) for categories of intermediate and high
oleic acid consumption compared with the low consump-
tion were 0.48 (0.23–0.97) and 0.37 (0.16–0.85), respect-
ively. Assessing monounsaturated fatty acid and oleic acid
consumption as continuous variables, there was evidence
of an inverse association, but these associations were of
borderline significance (Table 3).
In table 4, the results of the analyses of the association
of nutrient intake with DR stratified by the diabetes dur-
ation (≤ 8 years vs > 8 years) are shown. The OR values
did not materially change in the associations, but the in-
takes of monounsaturated fatty acids and oleic acid were
inversely associated with DR in the participants with a
duration of diabetes > 8 years.
Discussion
The findings of the present study indicate that in type 2
diabetic patients from our region, the presence of
Table 1 Clinical characteristics of patients with diabetic
retinopathy (DR) and patients with no retinopathy (no DR)
Characteristics No DR
(n = 148)
DR
(n = 146)
p value*
Age (years), mean (SD) 57.9 (10.3) 60.5 (8.8) 0.021
Men, % (n) 52.0 (77) 50.0 (73) 0.816
Non Caucasian, % (n) 3.4 (5) 4.1 (6) 0.769
Educational level, % (n) 0.001
≤ Primary 60.8 (90) 77.4 (113)
Secondary 27.0 (40) 20.5 (30)
University 12.2 (18) 2.1 (3)
Tobacco use, % (n) 0.629
Never smoker 45.3 (67) 50.7 (74)
Former smoker 33.8 (50) 29.5 (43)
Current smoker 20.9 (31) 19.9 (29)
Physical activity,% (n) 0.045
Active 66.2 (98) 55.9 (81)
Sedentary 33.8 (50) 44.1 (64)
HbA1c (%), mean (SD) 7.3 (1.2) 8.3 (1.4) < 0.001
Diabetes duration (years),
mean (SD)
7.1 (5.5) 14.1 (9.9) < 0.001
Body mass index, Kg/m2,
mean (SD)
31.3 (5.1) 32.0 (5.5) 0.273
Waist circumference (cm),
mean (SD)
104.2 (11.9) 107.8 (11.9) 0.010
Systolic blood pressure
(mmHg), mean (SD)
134.3 (15.5) 145.0 (19.9) < 0.001
Diastolic blood pressure
(mmHg), mean (SD)
76.5 (10.5) 77.1 (11.1) 0.628
Total cholesterol
(mg/dL), mean (SD)
185.7 (36.6) 184.8 (36.1) 0.822
HDL-cholesterol (mg/dL),
mean (SD)
48.5 (10.7) 52.1 (15) 0.021
LDL-cholesterol (mg/dL),
mean (SD)
111 (30.7) 106.9 (30.1) 0.182
Triglycerides (mg/dL) 138.6 (81.8) 140.5 (120) 0.879
Diabetes treatment, % (n) < 0.001
Oral agents 64.2 (95) 43.8 (64)
Insulin + oral agents 8.8 (13) 41.8 (61)
Insulin 2.7 (4) 12.3 (18)
Diet only 24.3 (36) 2.1 (3)
*p-value from Chi-squared or Fisher’s exact tests for comparison of qualitative
variables and Student’s t tests for comparison of quantitative variables. SD
standard deviation, HbA1c glycated haemoglobin, HDL-cholesterol high-density
lipoprotein cholesterol, LDL-cholesterol low-density lipoprotein cholesterol
Table 2 Mean daily nutrient intake of patients with diabetic
retinopathy (DR) and those without retinopathy (no DR)
Nutrient intake No DR
(n = 148)
DR
(n = 146)
p-value*
Energy intake (kcal) 2198 (581) 2088 (581) 0.105
Protein (g) 108.3 (30.1) 107.1 (37.4) 0.776
Carbohydrate (g) 232 (76) 222.1 (79.6) 0.275
Fibre (g) 28.3 (8) 26.3 (7.4) 0.032
Total fat (g) 92 (27) 85.7 (28.8) 0.054
Saturated fatty acids (g) 25.2 (9) 23.1 (10) 0.052
Monounsaturated
fatty acids (g)
43.6 (12.8) 39.9 (14.2) 0.018
Polyunsaturated
fatty acids (g)
16.1 (7.0) 16 (7.7) 0.842
Omega 3 (g) 1.77 (0.71) 1.78 (1.05) 0.921
Omega 6 (g) 14.2 (6.6) 14 (7.2) 0.817
Trans fat (g) 1.13 (0.94) 1.05 (0.97) 0.503
Palmitic acid (g) 15.1 (4.7) 13.9 (5.2) 0.043
Stearic acid (g) 5.92 (2.16) 5.49 (2.83) 0.145
Oleic acid (g) 41.2 (12.2) 37.5 (13.5) 0.016
Linoleic acid (g) 14.1 (6.6) 13.9 (7.2) 0.813
*p-value for Student’s t test. All values are means (SD). SD: standard deviation
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Table 3 Association between macronutrient intake and diabetic retinopathy (DR) in case–control study
Nutrient intake No DR/DR ORa (95 % CI) p-trendb ORc (95 % CI) p-trendb
Energy intake (kcal) Per 1000 cals 148/146 0.81 (0.52; 1.26) 0.76 (0.48; 1.23)
≤ 1849 46/52 1.00 0.364 1.00 0.377
1850 – 2272 47/51 0.77 (0.41; 1.45) 0.80 (0.40; 1.59)
≥ 2273 55/43 0.75 (0.40; 1.40) 0.73 (0.37; 1.46)
Protein (g) Per 10 g 148/146 1.03 (0.92; 1.14) 1.03 (0.91;1.17)
≤ 92.9 48/49 1.00 0.865 1.00 0.645
93.0–117.6 51/48 0.98 (0.51; 1.90) 1.15 (0.56; 2.37)
≥ 117.7 49/49 1.09 (0.46; 2.56) 1.24 (0.49; 3.16)
Carbohydrate (g) Per 100 g 148/146 1.49 (0.80; 2.77) 1.58 (0.80; 3.12)
≤ 189.6 45/53 1.00 0.859 1.00 0.729
189.7–234.0 47/51 0.95 (0.49; 1.82) 1.09 (0.53; 2.23)
≥ 234.1 56/42 0.93 (0.39; 2.21) 1.18 (0.45; 3.09)
Fibre (g) Per 10 g 148/146 0.74 (0.47;1.15) 0.83 (0.50; 1.36)
≤ 23.4 41/56 1.00 0.301 1.00 0.421
23.5–29.2 51/48 0.67 (0.36; 1.27) 0.55 (0.28; 1.11)
≥ 29.3 56/42 0.69 (0.33; 1.46) 0.76 (0.33; 1.76)
Total fat (g) Per 10 g 148/146 0.83 (0.69;1.01) 0.86 (0.70; 1.06)
≤ 76.3 43/54 1.00 0.194 1.00 0.275
76.4 – 96.2 52/46 0.53 (0.27; 1.06) 0.59 (0.27; 1.25)
≥ 96.3 53/46 0.58 (0.24; 1.39) 0.60 (0.23; 1.55)
Saturated fatty acids (g) Per 10 g 148/146 0.56 (0.33; 0.95) 0.64 (0.36; 1.14)
≤ 19.2 45/53 1.00 0.052 0.133
19.3 – 26.6 45/52 0.81 (0.41; 1.61) 0.63 (0.30; 1.33)
≥ 26.7 58/41 0.42 (0.18; 1.00) 0.49 (0.19; 1.26)
Mono-unsaturated fatty acids (g) Per 10 g 148/146 0.76 (0.58; 1.01) 0.74 (0.55;1.00)
≤ 36.0 39/59 1.00 0.050 1.00 0.034
36.1 – 46.2 53/45 0.53 (0.28; 1.01) 0.46 (0.22; 0.93)
≥ 46.3 56/42 0.49 (0.23; 1.03) 0.42 (0.18; 0.97)
Poly-unsaturated fatty acids (g) Per 10 g 148/146 1.12 (0.72;1.74) 1.27 (0.80;2.02)
≤ 12.3 45/53 1.00 0.804 1.00 0.900
12.4 – 16.6 52/46 0.74 (0.38; 1.45) 0.84 (0.41; 1.75)
≥ 17.7 51/47 0.91 (0.40; 2.07) 1.07 (0.44; 2.64)
Omega 3 (g) Per 1 g 148/146 1.11 (0.80; 1.55) 0.99 (0.69; 1.41)
≤1.43 50/48 1.00 0.909 1.00 0.927
1.44 – 1.91 47/51 1.14 (0.61; 2.15) 1.25 (0.62; 2.52)
≥ 1.92 51/47 0.95 (0.45; 2.00) 0.95 (0.41; 2.16)
Omega 6 (g) Per 10 g 148/146 1.09 (0.70; 1.71) 1.27 (0.79;2.05)
≤10.3 43/55 1.00 0.634 1.00 0.851
10.4 – 14.8 56/42 0.61 (0.31; 1.19) 0.77 (0.37; 1.60)
≥ 14.9 49/49 0.83 (0.37; 1.87) 1.10 (0.45; 2.67)
Trans fat (g) Per 1 g 148/146 1.03 (0.73; 1.45) 1.12 (0.76; 1.65)
≤ 0.61 41/56 1.00 0.325 1.00 0.810
0.62 – 1.09 54/45 0.64 (0.34; 1.22) 0.64 (0.32; 1.31)
≥1.10 53/45 0.70 (0.38; 1.46) 0.93 (0.41; 2.07)
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diabetic retinopathy is related to a lower intake of oleic
acid. Low oleic acid intake showed a clear relationship
with diabetes duration, revealing that the association be-
tween the low intake of this nutrient in patients with ret-
inopathy increased as the disease duration lengthened.
However, in a study with a cross-sectional design it is
not possible to differentiate the relative contributions of
disease duration and specific dietary intakes. Addition-
ally, the effect of long-term hyperglycemia to the devel-
opment of DR can only be explored in a long-term
Table 3 Association between macronutrient intake and diabetic retinopathy (DR) in case–control study (Continued)
Palmitic acid (g) Per 10 g 148/146 0.27 (0.09; 0.80) 0.32 (0.10; 1.06)
≤12.1 44/53 1.00 0.029 1.00 0.077
12.2 – 15.8 45/54 0.82 (0.42; 1.60) 0.67 (0.32; 1.41)
≥15.9 59/39 0.35 (0.14; 0.87) 0.41 (0.15; 1.01)
Stearic acid (g) Per 1 g 148/146 0.92 (0.76; 1.12) 0.98 (0.81; 1.20)
≤4.52 41/56 1.00 0.050 1.00 0.131
4.53 – 6.26 52/47 0.55 (0.28; 1.09) 0.43(0.20; 0.92)
≥6.27 55/43 0.43 (0.18; 1.00) 0.49 (0.19; 1.25)
Oleic acid (g) Per 10 g 148/146 0.76 (0.57; 1.00) 0.74 (0.54; 1.01)
≤32.2 38/59 1.00 0.019 1.00 0.017
32.3 – 43.6 52/47 0.56 (0.29; 1.06) 0.48 (0.23; 0.97)
≥43.6 58/40 0.41 (0.20; 0.88) 0.37 (0.16; 0.85)
Linoleic acid (g) Per 10 g 148/146 1.09 (0.70; 1.71) 1.27 (0.79; 2.05)
≤10.3 43/55 1.00 0.512 0.909
10.4 – 14.7 55/43 0.61 (0.31; 1.19) 0.77 (0.37; 1.61)
≥14.8 50/48 0.77 (0.35; 1.72) 0.95 (0.39; 2.31)
aAdjusted for sex, age, diabetes duration and energy intake. bp value for linear trends examined using likelihood ratio tests. cAdjusted for sex, age, diabetes
duration, energy intake, educational level, physical activity, waist circumference, systolic blood pressure, HDL-cholesterol and diabetes treatment. No DR Diabetic
no retinopathy, DR diabetic retinopathy, OR Odds ratio
Table 4 Odds ratios (OR) and corresponding 95 % confidence interval (CI) of diabetic retinopathy (DR) by nutrient intake according
to duration of diabetes
All cases (148/146) Duration of diabetes
≤ 8 years (102/53)
Duration of diabetes
> 8 years (46/93)
Nutrient intake ORa (95 % CI) ORa (95 % CI) ORa (95 % CI)
Energy intake (kcal) Per 1000 cal 0.76 (0.48; 1.23) 0.76 (0.41; 1.39) 0.85 (0.39; 1.86)
Protein (g) Per 10 g 1.03 (0.91; 1.17) 1.05 (0.90; 1.21) 1.07 (0.82; 1.39)
Carbohydrate (g) Per 100 g 1.58 (0.80; 3.12) 0.86 (0.34; 2.20) 3.05 (0.96; 9.72)
Fibre (g) Per 10 g 0.83 (0.50;1.36) 0.42 (0.19; 0.93) 1.44 (0.69; 3.03)
Total fat (g) Per 10 g 0.86 (0.70; 1.06) 1.08 (0.80; 1.47) 0.70 (0.51; 0.97)
Saturated fatty acids (g) Per 10 g 0.64 (0.36; 1.14) 0.83 (0.40; 1.72) 0.43 (0.18; 1.05)
Mono-unsaturated
fatty acids (g)
Per 10 g 0.74 (0.55; 1.00) 1.17 (0.76; 1.80) 0.49 (0.30; 0.81)
Poly-unsaturated
fatty acids (g)
Per 10 g 1.27 (0.80; 2.02) 1.07 (0.54; 2.11) 1.42 (0.69; 2.91)
Omega 3 (g) Per 1 g 0.99 (0.69; 1.41) 1.23 (0.71; 2.14) 0.59 (0.25; 1.39)
Omega 6 (g) Per 10 g 1.27 (0.79; 2.05) 1.01 (0.50; 2.04) 1.50 (0.71; 3.17)
Trans fat (g) Per 1 g 1.12 (0.76; 1.65) 1.24 (0.67; 2.30) 0.95 (0.54; 1.67)
Palmitic acid (g) Per 10 g 0.33 (0.10;1.06) 1.03 (0.23; 4.71) 0.10 (0.01; 0.62)
Stearic acid (g) Per 1 g 0.98 (0.81;1.20) 1.05 (0.84; 1.32) 0.80 (0.55; 1.17)
Oleic acid (g) Per 10 g 0.74 (0.54;1.01) 1.16 (0.74; 1.80) 0.49 (0.29; 0.81)
Linoleic acid (g) Per 10 g 1.27 (0.79;2.05) 1.01 (0.50; 2.03) 1.50 (0.71; 3.18)
aAdjusted for sex, age, diabetes duration, energy intake, educational level, physical activity, waist circumference, systolic blood pressure, HDL-cholesterol and
diabetes treatment. CI interval confidence, OR Odds ratio
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prospective study. Oleic acid represents more than 90 %
of the monounsaturated fatty acid intake of these pa-
tients, with the consumption of olive oil being the main
source in Spain. Although the patients with retinopathy
also showed a lower saturated fat intake, this association
did not reach statistical significance.
A potential role of unsaturated fatty acids was initially de-
scribed in two intervention studies carried out in the 1980s
[4, 5]. The first study showed a preventive effect of a lino-
leic acid – rich diet on the development of microangiopathy
and the progression of diabetic retinopathy in T2DM [4].
The second intervention study confirmed the protective
role of a high polyunsaturated fatty acid diet compared with
a low-carbohydrate diet in the development of retinopathy
in T2DM patients [5]. A recent post hoc analysis of a co-
hort of patients with type 2 diabetes in the PREDIMED trial
described a potential protective effect between MedDiet
supplemented with extra virgin olive oil and prevention of
diabetic retinopathy [6]. Our results also illustrate an asso-
ciation between the presence of DR and intake of monoun-
saturated fatty acids and oleic acid in patients with T2DM,
without other late diabetic complications, in the same geo-
graphical area. A previous prospective study in Spain
showed the potential protective role of polyunsaturated and
monounsaturated fatty acids in the development of dia-
betic complications in a small sample of patients with
type 1 and type 2 diabetes [18] Olive oil is one of the
main components of the Mediterranean diet, a diet that
has demonstrated a significant effect in the prevention
of cardiovascular disease [19]. Current and previous
results point to the protective role that poly- and
monounsaturated fatty acids may have, not only on
macrovascular but also on microvascular beds of dia-
betic subjects. Additionally, although oleic acid is the
main component of olive oil, many other substances in
this fat source, especially anti-oxidants and anti-
inflammatory polyphenols, could play a neuroprotective
role in the retina [20–22]. A higher consumption of
extra virgin olive oil, with a high content in oleic acid
and polyphenols, could have exerted anti-inflammatory
effects with a beneficial impact on the onset and pro-
gression of retinal damage.
Concerning other dietary fat components, we did not
find an association with omega-3 fatty acid intake or
polyunsaturated fatty acids. Although these fatty acids
have been shown to have anti-inflammatory properties,
potentially involved in the pathogenesis of DR, we could
not find an association. The results showed a lower pal-
mitic acid intake also in patients with DR. This seems to
be related, at least in part, to a lower intake of saturated
fat in patients with DR. However, after adjustment for
potential confounding variables, this association disap-
peared (Table 3). Nevertheless, we can not rule out a po-
tential association of other components of dietary fat in
the development of retinopathy, especially in popula-
tions with different patterns of fat intake.
Previous studies have described associations of fruit
consumption, higher fibre and carbohydrate intake, and
lower protein intake with a protective effect on retinop-
athy [7–9]. However, we were not able to show any differ-
ence in protein, fibre or carbohydrate intake between the
patients with and without retinopathy after adjusting for
confounding factors. Except for the three intervention
studies mentioned above, all other studies in this area, in-
cluding ours, have been cross-sectional. Therefore, pro-
spective studies are needed, as are intervention trials using
olive oil nutritional supplementation to target populations
with diabetic retinopathy and other eye diseases.
The main limitation of our study is its cross-sectional
design, which prevents the adoption of any conclusions
about the causality of any nutritional factors in retinop-
athy. We also acknowledge that patients with DR had dis-
tinct clinical characteristics. Some of these clinical
features are intrinsically associated with diabetic retinop-
athy, e.g., hypertension and longer diabetes duration,
which is in turn associated with poorer glycaemic control
and more complex hypoglycaemic treatment regimens.
Additionally, we were unable to detect other habits or ex-
ternal factors that may have been associated with the
lower consumption of specific nutrients. However, the
clinical characteristics of the studied patients are similar
to those recently described in our region [2]. Additionally,
it should be noted that this study was performed in pa-
tients from just one province in Spain; thus, the current
results may not be generalized to other populations with a
different pattern of monounsaturated fatty acid and/or
oleic acid intake. Finally, the dietary intake was evaluated
through a FFQ that evaluates foot intake only over the
previous one-year period; however, we have shown that
this FFQ is representative of previous longer time period
food intake (up to 5 years) [13].
Conclusions
In conclusion, a low intake of monounsaturated fatty
acids and oleic acid is associated with the presence of
retinopathy in type 2 diabetic patients from the Mediter-
ranean region. These and previous findings highlight the
potential role of nutrients in the prevention of the devel-
opment and/or progression of diabetic retinopathy. Fur-
ther research is needed in this area, especially research
based on prospective studies.
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